Trials / Completed
CompletedNCT03771352
Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism
A Prospective Multi-Center Clinical Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RxLAL) With the Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- RxSight, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
For patients undergoing cataract surgery, the purpose of this study is to evaluate a patient's far vision without glasses and quality of vision after implantation and UV treatment of the RxSight Light Adjustable Lens (RxLAL).Following completion of all light treatments, the patient's far vision without glasses and quality of vision will be assessed 6 months postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RxSight RxLAL | The patients will be assessed for 6 months |
Timeline
- Start date
- 2018-06-19
- Primary completion
- 2019-07-01
- Completion
- 2020-07-01
- First posted
- 2018-12-11
- Last updated
- 2021-06-09
- Results posted
- 2021-05-25
Locations
3 sites across 2 countries: Germany, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03771352. Inclusion in this directory is not an endorsement.